secwatch.observer — SEC 8-K summary
======================================

Issuer:     SRx Health Solutions, Inc. (SRXH)
CIK:        0001471727
Form:       8-K
Filed at:   2024-10-18T23:59:59+00:00
Accession:  0001493152-24-041494
Event type: m_and_a
Sentiment:  positive
Materiality: 0.85
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Better Choice expects combined 2025 revenue ~$270M, EBITDA ~$10M; SRx Health acquisition close imminent
--------------------------------------------------------------------------------

- Combined 2025 pro forma revenue over $270M and EBITDA over $10M, based on management assumptions.
- Transaction expected to close late Q4 2024 or early Q1 2025; all-stock deal valued at ~$125M.
- Combined TTM revenue $235M (+25% QoQ); expected annual cost savings ~$1.7M.
- Better Choice Q2 2024 adjusted EBITDA near break-even (-$0.03M); SRx Health had CAD$180M revenue in 2023.
- Pro forma fully diluted shares 22.9M; insiders own ~75%; net tangible book value $4.07/share.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1471727/000149315224041494/0001493152-24-041494-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1471727/000149315224041494/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-041494

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer